| 1º - NCLEX CRUSADE ACADEMY TEST - 6 ARTERIAL BLOOD GAS PRT 2 | 2026-03-25 | 25 | 0 |
| 2º - NCLEX CRUSADE ACADEMY TEST - 5 ASTHMA DISEASE | 2026-03-25 | 25 | 0 |
| 3º - NCLEX CRUSADE ACADEMY TEST - 4 RESPIRATORY NEXT-GEN CASE STUDIES | 2026-03-25 | 25 | 0 |
| 4º - NCLEX CRUSADE ACADEMY TEST - 3 EMPHYSEMA AND TYPES OF OXYGEN DELIVERY SYSTEM | 2026-03-25 | 25 | 0 |
| 5º - NCLEX CRUSADE ACADEMY TEST - 2 COPD | 2026-03-25 | 25 | 0 |
| 6º - NCLEX CRUSADE ACADEMY TEST - 1 RESPIRATORY DISORDERS | 2026-03-25 | 25 | 0 |
| 7º - NCLEX CRUSADE ACADEMY TEST - 20 NEUROLOGICAL | 2026-03-25 | 25 | 0 |
| 8º - NCLEX CRUSADE ACADEMY TEST - 19 HEAD INJURY | 2026-03-24 | 20 | 0 |
| 9º - NCLEX CRUSADE ACADEMY TEST - 18 NEUROLOGICAL DISORDERS | 2026-03-24 | 20 | 0 |
| 10º - NCLEX_CRUSADE_ACADEMY TEST - 17 BIOLOGYCAL_WARFARE_AGENTS | 2026-03-24 | 18 | 0 |
| 11º - NCLEX_CRUSADE_ACADEMY TEST - 16 COMMON_COMMUNICABLE_DISEASES_OF_CHILDHOOD | 2026-03-24 | 35 | 0 |
| 12º - Sistemi di controllo di gestione | 2026-03-24 | 136 | 0 |
| 13º - organizzazione e contabilità delle amministrazioni e dei servizi pubblici | 2026-03-24 | 4 | 0 |
| 14º - Linguistica italiana daypo 2 | 2026-03-24 | 1 | 0 |
| 15º - G3 | 2026-03-24 | 35 | 0 |
| 16º - Fisiologica (terzo set) | 2026-03-24 | 31 | 1 |
| 17º - ANATOMIA COMPARATA E CITOLOGIA | 2026-03-24 | 7 | 2 |
| 18º - VENOM-CHE | 2026-03-24 | 103 | 5 |
| 19º - NCLEX_CRUSADE_ACADEMY TEST - 15 PEAK_AND_TROUGH_VALUES_OF_ANTIBIOTICS_+ | 2026-03-24 | 30 | 0 |
| 20º - NCLEX_CRUSADE_ACADEMY TEST - 14 ANTIBIOTIC_AND_ANTIRETROVIRAL_THERAPY | 2026-03-24 | 35 | 0 |
| 21º - Teoría General y Especial de la Neurosis | 2026-03-24 | 100 | 5 |
| 22º - NCLEX_CRUSADE_ACADEMY TEST - 13 HEALTH_CARE_ASSOCIATED_NOSOCOMIAL_INFECTIONS | 2026-03-24 | 35 | 0 |
| 23º - NCLEX_CRUSADE_ACADEMY TEST -12 CLASSIFICATION_OF_HEPATITIS | 2026-03-24 | 35 | 0 |
| 24º - NCLEX_CRUSADE_ACADEMY TEST - 11 TRANSMISSION_BASED_PRECAUTIONS | 2026-03-24 | 35 | 0 |
| 25º - NCLEX_CRUSADE_ACADEMY TEST - 10 USE_OF_PERSONAL_PROTECTIVE_EQUIPMENT | 2026-03-24 | 35 | 0 |
SHOW MORE |
